Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) injections successfully treated a woman's steroid-resistant hair loss, causing hair to regrow within a month.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

The new composite material is safe and has anticoagulant properties.

The conclusion is that future trials should report specific details about the PRP composition to better understand its effects on urologic conditions.

The new treatment effectively reduces artery blockage and inflammation in atherosclerosis.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

The document concludes that various skin conditions have specific treatments and that adequate calcium intake may prevent osteoporosis.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A woman with Fox-Fordyce disease had symptom relief using tretinoin cream.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

A 16-year-old boy's arm hair grew more after wearing a splint, but it returned to normal in 8 months.

New methods to make oxasteroids show promise for medical treatments like osteoporosis and breast cancer.

The treatment successfully reopened blood flow in most patients and extended the use of their dialysis access with low risk.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

A woman experienced hair loss, nail changes, bone marrow suppression, and low blood protein after taking azathioprine.

Cortisone tapering may help improve severe myasthenia gravis and alopecia areata after thymectomy.

Deuruxolitinib and baricitinib are effective for treating severe alopecia areata.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Autoimmune thyroid disease raises the risk of many health issues but lowers the risk of lung cancer and allergic rhinitis.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Brepocitinib reduces interferon signaling in hidradenitis suppurativa patients.